PharmiWeb.com - Global Pharma News & Resources
28-Jun-2019

Injectable Drug Delivery Devices Market has recorded a growth rate of 11.5% by 2023

Injectable Drug Delivery Devices Market has recorded a growth rate of 11.5% during the forecast period (2018-2023).

The global injectable drug delivery devices market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2017 to 2023. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2017 to 2023.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/11001

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global injectable drug delivery devices market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2017 and the growth rate of the global injectable drug delivery devices market?

What is the market drivers, restrains, opportunities governing the global injectable drug delivery devices market?

Which are the largest and the fastest growing segments in the global injectable drug delivery devices market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/injectable-drug-delivery-devices-market-11001

Injectable Drug Delivery Devices Market Information by By Devices (Conventional Injection Devices, Self-Injection Devices), By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Cancer), By Usage Pattern (Curative pattern, Immunization), By Site of Delivery (Intramuscular, Subcutaneous, Intradermal), By Distribution Channel (Hospital amp; Retail Pharmacies, Online platforms), By Facility of Use (Hospitals and Clinics, Home Care Settings) and By Region ndash; Global Forecasts till 2023

Market analysis

Advances in technology and innovation are permitting their use in progressively complex delivery systems. A range of gadgets fall under the section of injectable drug delivery devices including needle-free injectors, auto and pen injectors and conventional syringes. Interest for such gadgets has kept on expanding lately as they are being utilized to treatment of ailments that seeing a high rate of prevalence. Presentation of cutting edge gadgets with predominant functional abilities is positively affecting the global injectable drug delivery devices market. Other factor that can be connected with the market's development incorporate expanding pervasiveness of interminable sicknesses, developing appropriation of self-injectable gadgets, and rising FDA endorsements. The market has recorded the growth rate of 11.5% during the forecast period (2018-2023).

Market segmentation

Based on its devices, the global injectable drug delivery devices market is divided into self-injection and conventional injection devices. On the basis of its therapeutic application, the market is sectioned as cancer, hormonal disorders and autoimmune diseases. By usage pattern, it is classified as immunization and curative pattern. Based on its site of delivery, the market is segmented as subcutaneous, intramuscular and intradermal. By facility of use, the market is divided as hospital and retail pharmacies and online platforms. Based on its facility of use, the market is categorized into home care settings and hospitals and clinics.

Regional analysis

Geographically, the global injectable drug delivery devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Becton, Dickinson and Company, Eli Lilly and Company, F.Hoffmann-La Roche AG, Eisai Co., Ltd., Antares Pharma, AstraZeneca, among others are the major players in the global injectable drug delivery devices market.

Few Significant from Table Of Contents

Injectable Drug Delivery Devices Market- Global Forecast 2023

1 Report Prologue

2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions

3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of chronic diseases
4.2.2 Growing adoption of self-injectable devices
4.2.3 Rising FDA approvals
4.2.4 Drivers Impact Analysis
4.3 Restraints
4.3.1 Risks of cross-contamination
4.3.2 Increasing cost of high-end products
4.3.3 Restraints Impact Analysis
4.4 Opportunity
4.4.1 Increasing campaigns of vaccination in developing economies of the Asia-Pacific region
4.5 Macroeconomic Indicators
4.6 Market Trend
4.6.1 Increasing use of auto-injectors against allergies

5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 Ramp;D and Designing
5.1.2 Manufacturing
5.1.3 Distribution amp; Sales
5.1.4 Post-Sales Review
5.2 Porterrsquo;s Five Forces Model
5.2.1 Threat of New Entrants
5.2.2 Bargaining Power of Suppliers
5.2.3 Threat of Substitutes
5.2.4 Bargaining Power of Buyers
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
5.5 Demand amp; Supply: Gap Analysis

6 Global Injectable Drug Delivery Devices Market, By Devices
6.1 Introduction
6.2 Conventional Injection Devices
6.3 Self-Injection Devices

7 Global Injectable Drug Delivery Devices Market, By Therapeutic Application
7.1 Introduction
7.2 Autoimmune Diseases
7.3 Hormonal Disorders
7.4 Cancer

8 Global Injectable Drug Delivery Devices Market, By Usage Pattern
8.1 Introduction
8.2 Curative pattern
8.3 Immunization

9 Global Injectable Drug Delivery Devices Market, By Site of Delivery
9.1 Introduction
9.2 Intramuscular
9.3 Subcutaneous
9.4 Intra Dermal

10 Global Injectable Drug Delivery Devices Market, By Distribution Channel
10.1 Introduction
10.2 Hospital amp; Retail Pharmacies
10.3 Online Platforms

11 Global Injectable Drug Delivery Devices Market, By Facility of Use
11.1 Introduction
11.2 Hospitals and Clinics
11.3 Home Care Settings

12 Global Injectable Drug Delivery Devices Market, By Region
12.1 Introduction
12.2 Americas
12.2.1 North America
12.2.1.1 U.S
12.2.1.2 Canada
12.2.1.3 South America
12.3 Europe
12.3.1 Western Europe
12.3.1.1 Germany
12.3.1.2 U.K
12.3.1.3 France
12.3.1.4 Italy
12.3.1.5 Spain
12.3.1.6 Rest of Western Europe
12.3.2 Eastern Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Republic of Korea
12.4.5 Australia
12.4.6 Rest of Asia Pacific
12.5 Middle East amp; Africa
12.5.1 Middle East
12.5.2 Africa

13 Competitive Landscape
13.1 Introduction

14 Company Profile
14.1 Eisai Co., Ltd.
14.1.1 Company Overview
14.1.2 Financial Overview
14.1.3 Products Offering
14.1.4 Key Developments
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 Antares Pharma
14.2.1 Company Overview
14.2.2 Financial Overview
14.2.3 Products Offering
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 AstraZeneca
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Pipeline Products
14.3.4 Key Developments
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 Becton, Dickinson and Company
14.4.1 Company Overview
14.4.2 Financial Overview
14.4.3 Products Offering
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key Strategy
14.5 Eli Lilly and Company
14.5.1 Company Overview
14.5.2 Financial Overview
14.5.3 Products Offering
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key Strategy
14.6 F. Hoffmann-La Roche AG
14.6.1 Company Overview
14.6.2 Financial Overview
14.6.3 Products Offering
14.6.4 Key Developments
14.6.5 SWOT Analysis
14.6.6 Key Strategy
14.7 Johnson amp; Johnson Services Inc.
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products Offering
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 Mylan N.V.
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products Offering
14.8.4 Key Developments
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 Novartis AG
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Products Offering
14.9.4 Key Developments
14.9.5 SWOT Analysis
14.9.6 Key Strategy
14.1 Novo Nordisk
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Products Offering
14.10.4 Key Developments
14.10.5 SWOT Analysis
14.10.6 Key Strategy
14.11 Pfizer Inc.
14.11.1 Company Overview
14.11.2 Financial Overview
14.11.3 Products Offering
14.11.4 Key Developments
14.11.5 SWOT Analysis
14.11.6 Key Strategy
14.12 Sanofi
14.12.1 Company Overview
14.12.2 Financial Overview
14.12.3 Products Offering
14.12.4 Key Developments
14.12.5 SWOT Analysis
14.12.6 Key Strategy
14.13 Teva Pharmaceutical Industries Ltd
14.13.1 Company Overview
14.13.2 Financial Overview
14.13.3 Products Offering
14.13.4 Key Developments
14.13.5 SWOT Analysis
14.13.6 Key Strategy
14.14 Inovio Pharmaceuticals Inc.
14.14.1 Company Overview
14.14.2 Financial Overview
14.14.3 Products Offering
14.14.4 Key Developments
14.14.5 SWOT Analysis
14.14.6 Key Strategy

15 Appendix
15.1 Discussion Blue Print

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/11001

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making a purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 28-Jun-2019